BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:`PENTRA: Topical Antibodies´
DTSTART:20130531T140000
DTEND:20130531T150000
DTSTAMP:20260408T121152Z
UID:14cb8fdcb79013d5fdddfde17d2238da9e356d9e08772a8e38015ddb
CATEGORIES:Conferences - Seminars
DESCRIPTION:Dr. Kretzschmar\, CSO Delenex Therapeutics\nExisting antibody 
 therapeutics need to be administered by injection which is obviously not c
 onvenient. Dr. Kretschmar is developing antibody-based therapeutics amenab
 le to needle-free application.\nhttp://www.delenex.ch
LOCATION:BCH 5310 https://plan.epfl.ch/?room==BCH%205310
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR